<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210717051911N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-08-14</date_registration>
      <primary_sponsor>The University of Lorestan</primary_sponsor>
      <public_title>Effect of Unified Transdiagnostic Treatment (UP) and  Roy's adaptation model in treatment of hypertension</public_title>
      <acronym></acronym>
      <scientific_title>A Comparison of the Effectiveness of Unified Transdiagnostic Treatment (UP) and Application of Roy's adaptation model on Blood Pressure, Alexithymia, Psychological Distress and Diet Adherence in People with Hypertension Comorbid with Stress</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57554</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The block randomization method is performed by the statistical consultant as follows: randomization is performed in three groups: unified transdiagnostic treatment, application of Roy's adaptation model and control. First, a list of eligible individuals is provided and coded. We first code the groups in Latin letters as follows: A = unified transdiagnostic treatment, B= application of Roy's adaptation model  and C = control group. In this study with three groups A, B, and C, we create the following six groups and assign a number from 1 to 6 to each group: ABC-ACB-BAC-BCA-CAB-CBA, Then, using the table of random numbers, we contract that if the numbers 1, 2, 3, 4, 5, and 6 appear in order, one of these blocks will be selected, and if another number appears, we will assume it to be void and move on to the next selection. We have obtained a random sequence of numbers with a table of random numbers that for each number we consider the desired order of assignment. In this way, the number of people in the groups will be approximately equal.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hypertension.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: after taking part in a pre-test in a separate meeting, the participants will have the Unified Transdiagnostic treatment which includes 8 basic treatment factors and targets important aspects of the processing and regulating emotions. Eight collective treatment sessions will focus on different factors and take 90 minutes long. These factors briefly include 1. Motivational development and education if needed 2. Psychological training and monitoring emotional experiences 3. Training on the awareness of the emotions 4. Re-cognitive assessment training 5.  Avoidance of excitement6. Understanding and tolerance of physical sensations 7. Situation-based emotional encounters 8. Prevention of recurrence of the symptoms. Intervention 2: The second intervention group: the Roy's adaptation model is implemented according to the steps of the nursing process, which are as follow: 1. Evaluation and recognition; 2. Nursing diagnosis; 3. Planning; 4. Implementation; 5. Assessment. In addition to the implementation of pre-tests, which is carried out on both the intervention and control group. In the intervention group, the first step is the evaluation and recognition form of Roy as well as the in-person interviews. Next, according to the obtained information, identification of incompatible behaviors, associated stimulations, and prioritizing these behaviors for the maladjusted and reformable behaviors, the objectives are determined and a suitable treatment program will be provided.The participants in the Roy's adaptation model intervention will be engaged in eight weekly treatment sessions for about an hour. Treatment steps details with respect to the identified stimuli in the implementation section are: 1. Hypertension disease familiarity (trained by a general doctor).2. Evaluating the important physiological parameters related to high blood pressure, such as nutrition and its effect on hypertension, and proposing solutions and behavioral trains by nutrition expert 3. Evaluating the other physiological parameters related to high blood pressure such as exercise, BMI, their effects on hypertension and education, and conducting suitable behavioral training by the general practitioner. 4. Proposing the methods for reducing stress, anxiety, and relaxing techniques by psychologist 5. Training methods to control anger, increase self-confidence, and positive self-assumption providing by psychologist 6. Teaching issues related to roles, responsibilities, social support, and taking drugs regularly 7. Convene training sessions related to taking part in social and religious events and avoiding isolation 8. Reviewing previous meetings. Intervention 3: The control group: 15 subjects will be randomly assigned to this group and do not receive any treatment for two months. At the end of the study, the subjects will receive whether Roy's adaptation model treatment or Unified Transdiagnostic   treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After deleting participants' identifying factors details, the information about the main consequences will be shared

When:
As the results are published

To whom:
Researchers working in universities and medical centers

Conditions:
In clinical and therapeutic work

Where to obtain:
Lorestan University Central Library, Adress: 5th Kilometer of Khorramabad-Boroujerd Highway, Khorramabad, Lorestan.  Phone:06633120661
researcher, Marziyeh Kolivand, Email  marzikolivand@yahoo.com

How to obtain:
If you are working in a university or scientific institution, it is necessary to provide the relevant document, and the reason for the need for the requested information and the type of relationship with the other study is requested.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marziyeh Kolivand</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shafagh2 Alley., Alavi 1 Street</address>
        <city>Azna</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6871611111</zip>
        <telephone>+98 66 4336 2078</telephone>
        <email>marzikolivand@yahoo.com</email>
        <affiliation>The University of Lorestan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marziyeh Kolivand</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shafagh2 Alley., Alavi 1 Street</address>
        <city>Azna</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6871611111</zip>
        <telephone>+98 66 4336 2078</telephone>
        <email>marzikolivand@yahoo.com</email>
        <affiliation>The University of Lorestan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Have a minimum score of 19 or higher on the stress subscale of the DASS-21 questionnaire
Being over 18 years old
Having the minimum physical and cognitive abilities necessary to participate in the interventions
Systolic blood pressure equal to or greater than 140 and diastolic blood pressure equal to or greater than 90 mm Hg
Have a history of at least six months of medication for high blood pressure treatment
Tendency to participate in treatment sessions</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Participate in other psychological interventions
Having a history of mental illness and taking psychotropic drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Essential (primary) hypertension</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: after taking part in a pre-test in a separate meeting, the participants will have the Unified Transdiagnostic treatment which includes 8 basic treatment factors and targets important aspects of the processing and regulating emotions. Eight collective treatment sessions will focus on different factors and take 90 minutes long. These factors briefly include 1. Motivational development and education if needed 2. Psychological training and monitoring emotional experiences 3. Training on the awareness of the emotions 4. Re-cognitive assessment training 5.  Avoidance of excitement6. Understanding and tolerance of physical sensations 7. Situation-based emotional encounters 8. Prevention of recurrence of the symptoms.</i_keyword>
      <i_keyword>The second intervention group: the Roy's adaptation model is implemented according to the steps of the nursing process, which are as follow: 1. Evaluation and recognition; 2. Nursing diagnosis; 3. Planning; 4. Implementation; 5. Assessment. In addition to the implementation of pre-tests, which is carried out on both the intervention and control group. In the intervention group, the first step is the evaluation and recognition form of Roy as well as the in-person interviews. Next, according to the obtained information, identification of incompatible behaviors, associated stimulations, and prioritizing these behaviors for the maladjusted and reformable behaviors, the objectives are determined and a suitable treatment program will be provided.The participants in the Roy's adaptation model intervention will be engaged in eight weekly treatment sessions for about an hour. Treatment steps details with respect to the identified stimuli in the implementation section are: 1. Hypertension disease familiarity (trained by a general doctor).2. Evaluating the important physiological parameters related to high blood pressure, such as nutrition and its effect on hypertension, and proposing solutions and behavioral trains by nutrition expert 3. Evaluating the other physiological parameters related to high blood pressure such as exercise, BMI, their effects on hypertension and education, and conducting suitable behavioral training by the general practitioner. 4. Proposing the methods for reducing stress, anxiety, and relaxing techniques by psychologist 5. Training methods to control anger, increase self-confidence, and positive self-assumption providing by psychologist 6. Teaching issues related to roles, responsibilities, social support, and taking drugs regularly 7. Convene training sessions related to taking part in social and religious events and avoiding isolation 8. Reviewing previous meetings</i_keyword>
      <i_keyword>The control group: 15 subjects will be randomly assigned to this group and do not receive any treatment for two months. At the end of the study, the subjects will receive whether Roy's adaptation model treatment or Unified Transdiagnostic   treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Psychological distress. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Depression Anxiety and Stress Scale.</prim_outcome>
      <prim_outcome>Alexithymia. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Toronto Alexithymia Scale.</prim_outcome>
      <prim_outcome>Diet Adherence. Timepoint: Before  intervention, The middle of intervention and  after intervention. Method of measurement: Diet information registration form.</prim_outcome>
      <prim_outcome>The amount of blood pressure systolic. Timepoint: Before  intervention, The middle of intervention and  after intervention. Method of measurement: Digital sphygmomanometer.</prim_outcome>
      <prim_outcome>The amount of blood pressure diastolic. Timepoint: Before  intervention, The middle of intervention and  after intervention. Method of measurement: Digital sphygmomanometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of Lorestan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-05</approval_date>
        <contact_name>Ethics committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Lorestan University of Medical Sciences, Shahid Anooshirvan Rezaei Square, Khorramabad, Lorestan. Khorramabad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
